Sumiaki Tanaka Selected Research

Sumiaki Tanaka Research Topics

Disease

3	Disease Progression 01/2021 - 11/2013
3	Systemic Scleroderma (Systemic Sclerosis) 01/2017 - 11/2013
2	Connective Tissue Diseases (Connective Tissue Disease) 12/2023 - 05/2008
2	Fever (Fevers) 12/2020 - 03/2007
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2020 - 01/2006
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 12/2011 - 12/2003
2	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 02/2009 - 05/2008
2	Granuloma 03/2007 - 12/2003
1	Fibrosis (Cirrhosis) 03/2024
1	Immunoglobulin G4-Related Disease 03/2024
1	Phlebitis 03/2024
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2023
1	Churg-Strauss Syndrome (Allergic Angiitis) 10/2023
1	Atopic Dermatitis (Atopic Eczema) 10/2023
1	Lymphadenopathy 01/2022
1	Synovitis 01/2022
1	Dermatomyositis (Dermatopolymyositis) 01/2021
1	Intracranial Vasospasm 01/2021
1	Consciousness Disorders 12/2020
1	Rhinitis 12/2020
1	digital ulcers 01/2017
1	Encephalitis (Encephalitis, Rasmussen) 11/2016
1	Pulmonary Hypertension 11/2016
1	Confusion (Bewilderment) 11/2016
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2011
1	Abdominal Pain (Pain, Abdominal) 02/2009
1	Neurologic Manifestations (Neurological Manifestations) 09/2008
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2008
1	Pneumonia (Pneumonitis) 05/2008
1	Bacteremia 03/2007
1	Vasculitis (Vasculitides) 03/2007
1	Asthma (Bronchial Asthma) 03/2007
1	Foreign-Body Granuloma (Granuloma, Foreign Body) 03/2007
1	Erythema 03/2007
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2006
1	Strongyloidiasis 01/2006
1	Osteoarthritis 08/2003
1	Inflammation (Inflammations) 08/2003
1	Arthritis (Polyarthritis) 08/2003
1	Rheumatoid Arthritis 08/2003

Drug/Important Bio-Agent (IBA)

6	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020 - 01/2006
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2011 - 12/2003
2	Immunoglobulin G (IgG)IBA 03/2024 - 12/2011
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 01/2006
2	Indicators and Reagents (Reagents)IBA 01/2014 - 11/2013
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 02/2009 - 05/2008
1	Immunoglobulins (Immunoglobulin)IBA 03/2024
1	Complement System Proteins (Complement)IBA 12/2023
1	Inosine Triphosphate (ITP)IBA 12/2023
1	dupilumabIBA 10/2023
1	mepolizumabIBA 10/2023
1	AutoantibodiesIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Bosentan (Tracleer)FDA Link 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2016
1	Prednisolone (Predate)FDA LinkGeneric 11/2016
1	ChemokinesIBA 11/2013
1	Immunoglobulin A (IgA)IBA 12/2011
1	Fc Receptors (Fc Receptor)IBA 12/2011
1	anticentromere antibodyIBA 09/2011
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2009
1	Pentamidine (NebuPent)FDA LinkGeneric 05/2008
1	Thymidine Monophosphate (TMP)IBA 05/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2007
1	alpha-DefensinsIBA 12/2003
1	Leukotriene B4IBA 08/2003
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 08/2003
1	Messenger RNA (mRNA)IBA 08/2003

Therapy/Procedure

5	Therapeutics 12/2023 - 08/2003
1	X-Ray Film 03/2007